Jaguar Health (NASDAQ:JAGX) | Finanzwire

Basculer en Français

10900	Companies
237504	Keywords
166414	Articles
127543	Press releases

Home
Companies
Jaguar Health

BRIEF

published on 07/18/2024 at 16:35, 2 years 1 month ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Crofelemer on July 23rd

Crofelemer Webcast Jaguar Health OnTarget Trial Cancer Supportive Care
PRESS RELEASE

published on 07/18/2024 at 16:30, 2 years 1 month ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
Jaguar Health announces webcast for cancer supportive care updates including OnTarget trial results. Make Cancer Less Shitty program expands with MCLS Ambassadors

Webcast Jaguar Health OnTarget Trial Cancer Supportive Care Make Cancer Less Shitty
BRIEF

published on 07/08/2024 at 16:35, 2 years 1 month ago

Jaguar Health Strengthens IP Protection with New European and Australian Patents

Crofelemer Jaguar Health Australian Patent European Patent SBS And CDDs
PRESS RELEASE

published on 07/08/2024 at 16:30, 2 years 1 month ago

Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025

Napo Pharmaceuticals Crofelemer Jaguar Health Patents Rare Disease

Accesswire

Published on 08/31/2026 at 08:10, 3 hours 15 minutes ago

EN China XLX Announces 2026 Interim Results
Published on 08/31/2026 at 02:05, 9 hours 20 minutes ago

Tunkillia Infill Drilling Confirms New High-grade Mineralisation Within Shallow Zone of Existing High-value 'Starter Pit' Outlines
Published on 08/29/2026 at 05:15, 2 days 6 hours ago

Norsemont Announces Restatement of Financial Statements
Published on 08/29/2026 at 03:20, 2 days 8 hours ago

BEACN Announces Financial Results for the Second Quarter of 2026
Published on 08/29/2026 at 01:15, 2 days 10 hours ago

Gamma Resources Announces Increase in Private Placement to $1,750,000 and Closing of First Tranche at $872,500

View all ACCESSWIRE

EQS Group

Published on 08/31/2026 at 10:35, 50 minutes ago

Deufol SE publishes two key reports: the half-year report 2026 with the operational figures for the first half of the year and the second voluntary sustainability report for the 2025 financial year.
Published on 08/31/2026 at 10:01, 1 hour 24 minutes ago

Sto SE & Co. KGaA Group turnover rises by 3.7 % to EUR 805.5 million by the end of June 2026
Published on 08/31/2026 at 10:00, 1 hour 25 minutes ago

BOOSTER Precision Components Holding GmbH publishes H1 2026 results
Published on 08/31/2026 at 09:30, 1 hour 55 minutes ago

HÖRMANN Industries publishes interim report for the first half of 2026
Published on 08/31/2026 at 09:12, 2 hours 13 minutes ago

Leasing success in Baar: new office building fully leased before construction start

Les Echos

Published on 08/31/2026 at 07:00, 4 hours 25 minutes ago

Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Published on 08/28/2026 at 06:55, 3 days 4 hours ago

Recticel Accelerates Profitable Growth
Published on 08/26/2026 at 18:02, 4 days 17 hours ago

Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 4 days 17 hours ago

Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 17:40, 4 days 17 hours ago

First half 2026 results

View all LES ECHOS COMFI WIRE